[1] |
Akita H, Kikuchi E, Hayakawa N, et al. Performance of diffusion-weighted MRI post-CT urography for the diagnosis of upper tract urothelial carcinoma: comparison with selective urine cytology sampling[J]. Clin Imaging, 2018, 52: 208-215.
|
[2] |
程亮, 徐嘉雯, 何佳佳, 等. 膀胱尿路上皮癌分子标记的临床应用进展[J]. 中华病理学杂志, 2011, 40(10): 714-717.
|
[3] |
Gunia S, Erbersdobler A, Koch S, et al. Protein gene product 9.5 is diagnostically helpful in delineating high-grade renal cell cancer involving the renal medullary/sinus region from invasive urothelial cell carcinoma of the renal pelvis[J]. Hum Pathol, 2013, 44(5): 712-717.
|
[4] |
徐亮,王杜娟,王雪,等. 肾集合管癌8例临床病理分析[J]. 临床与实验病理学杂志, 2020, 36(10): 1235-1237.
|
[5] |
Ohe C, Smith SC, Sirohi D, et al. Reappraisal of morphologic differences between renal medullary carcinoma, collecting duct carcinoma, and fumarate hydratase-deficient renal cell carcinoma[J]. Am J Surg Pathol. 2018, 42(3): 279-292.
|
[6] |
王跃, 贺慧颖. 上尿路尿路上皮癌368例根治标本的临床病理特点及预后分析[J]. 中华病理学杂志, 2016, 45(10): 681-686.
|
[7] |
谢欢, 刘四斌, 刘静. 肾实质浸润型尿路上皮癌CT表现[J]. 临床放射学杂志, 2020, 39(11): 2253-2256.
|
[8] |
丁竹, 肖荆, 张东兴, 等. CTU简易评分对肾实质浸润性肾盂癌与肾盂浸润性肾细胞癌鉴别诊断的临床研究[J]. 肿瘤影像学, 2023, 32(1): 41-46.
|
[9] |
王咏涛, 陈振东, 赵亦军, 等. 肾实质浸润型尿路上皮癌9例影像分析[J]. 现代实用医学, 2015, 27(2): 243-245.
|
[10] |
Zhu Q, Zhu W, Wu J, Chen W. Multidetector CT imaging features of invasive renal parenchyma urothelial carcinoma[J]. Br J Radiol, 2016, 89(1063): 20151068.
|
[11] |
Kubota Y, Hatakeyama S, Tanaka T, et al. Oncological outcomes of neoadjuvant chemotherapy in patients with locally advanced upper tract urothelial carcinoma: a multicenter study[J]. Oncotarget, 2017, 8(60): 101500-101508.
|
[12] |
Gutierrez CM, Alemozaffar M, Osunkoya AO. Invasive high-grade urothelial carcinoma of the bladder, renal pelvis, ureter, and prostatic urethra arising in a background of urothelial carcinoma with an inverted growth pattern: a contemporary clinicopathological analysis of 91 cases[J]. Hum Pathol, 2019, 92: 18-24.
|
[13] |
王炜,李先承,于洋,等. 肾实质浸润型尿路上皮癌的临床特点[J]. 微创泌尿外科杂志, 2017, 6(2): 106-108.
|
[14] |
谢大炜, 刘赛, 宋黎明, 等. 肾实质浸润型尿路上皮癌临床诊治特点分析[J]. 中华泌尿外科杂志, 2023, 44(1): 12-15.
|
[15] |
刘钊, 丁森泰, 吴海虎, 等. 肾实质浸润型尿路上皮癌的诊断与治疗[J]. 山东大学学报(医学版), 2013, 51(10): 93-97.
|
[16] |
Wong MN, Wu DJ, Lee CT, et al. Renal pelvic urothelial carcinoma with invasion into renal medulla can be redefined as PT2 to improve correlation with survival[J]. Mod Pathol, 2023, 36(6): 100140.
|
[17] |
常宏, 尚攀峰, 岳中瑾. 局部进展期上尿路尿路上皮癌的治疗研究进展[J]. 中华泌尿外科杂志, 2020, 41(5): 389-393.
|
[18] |
Kobayashi K, Saito T, Kitamura Y, et al. Effect of preoperative chemotherapy on survival of patients with upper urinary tract urothelial carcinoma clinically involving regional lymph nodes[J]. Int J Urol, 2016, 23(2): 153-158.
|
[19] |
Hara T, Furukawa J, Okamura Y, et al. The poor antitumor effect of pembrolizumab in advanced upper urothelial carcinoma with renal parenchymal invasion[J]. Int J Urology, 2023, 30(9): 779-786.
|
[20] |
Sassa N, Tsuzuki T, Fukatsu A, et al. Is pT3 urothelial carcinoma of the renal pelvis a homogeneous disease entity? Proposal for a new subcategory of the pT3 classification[J]. Histopathology, 2012, 61(4): 620-628.
|